Home » Bayer’s European Patent for Yaz Revoked by Board of Appeal
Bayer’s European Patent for Yaz Revoked by Board of Appeal
The European Patent Office’s Board of Appeal is revoking Bayer HealthCare’s formulation patent for its Yaz, Yasmin and Yasminelle products — a blow to the blockbuster line of birth control pills.
Generic Line
Generic Line
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May